欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号DE/V/0208/001
药品名称CEVAC Salmovac
活性成分
    • salmonella enteritidis 100000000.0 IU/ml
剂型Oral lyophilisate
上市许可持有人Ceva Tiergesundheit GmbH Kanzlerstraße 4 40472 Düsseldorf GERMANY
参考成员国 - 产品名称Germany (DE)
Salmovac 440
互认成员国 - 产品名称
    • Latvia (LV)
    • Bulgaria (BG)
    • Cyprus (CY)
    • Slovenia (SI)
    • Netherlands (NL)
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Poland (PL)
    • Lithuania (LT)
      GALLIVAC SE, liofilizatas geriamajai suspensijai
    • Czechia (CZ)
    • Romania (RO)
    • Austria (AT)
    • Slovakia (SK)
    • Belgium (BE)
      Cevac Salmovac
    • Denmark (DK)
    • Estonia (EE)
    • France (FR)
    • Croatia (HR)
    • Hungary (HU)
许可日期2003/04/17
最近更新日期2023/08/03
药物ATC编码
    • QI01AE01 salmonella
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：Full Dossier (art.5)
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase